By David Mittleman

Drug benefit companies are negotiating sweetheart deals with pharmaceutical companies at the expense of consumers, according to a report by USA Today. Under the complex arrangements, drug companies offer incentives for pharmacy benefit managers (drug benefit plans) to push expensive name-brand medications rather than equally effective and cheaper generic medications. The extra costs get passed along to consumers.

This practice came to a boil this week when Anthem, the nation’s largest health insurer, filed suit against Express Scripts, a pharmacy benefit manager.

A much larger issue is the availability and efficacy of generic and alternative medications. …read more